Later, this model was used to lay the foundation for the current study, providing definitive evidence that LIM-domain-only 1 (LMO1) synergizes with MYCN to result in a more penetrant and aggressively metastatic disease (9). The gene discussed is LMO1; the disease is metastatic neoplasm.